by Madaline Spencer | Sep 6, 2024
Corey Cutler, MD, Director of Adult Stem Cell Transplantation Program at Dana-Farber Cancer Institute in Boston and a Professor of Medicine at Harvard Medical School, discusses the approval of Niktimvo (axatilimab) for the treatment of chronic graft versus host...
by Madaline Spencer | Sep 5, 2024
Ryan Motte, PharmD, Clinical Pharmacist at Shields Health Solutions, discusses recent data concerning the global cancer burden among men and projections for the year 2050. Men are disproportionately affected by modifiable risk factors such as smoking and...
by Madaline Spencer | Sep 3, 2024
Arginine vasopressin (AVP) deficiency is a rare neuroendocrine disorder caused by the loss or impaired function of vasopressinergic neurons in the hypothalamus and posterior pituitary gland. This results in impaired synthesis and secretion of AVP. A deficiency of AVP...
by Madaline Spencer | Aug 30, 2024
David Katz, PhD, Chief Scientific Officer and Founder of Sparrow Pharmaceuticals, discusses how clofutriben addresses the challenges of hypercortisolism in Cushing’s syndrome. Cushing’s syndrome is a rare endocrine disorder caused by prolonged...
by Madaline Spencer | Aug 29, 2024
Carla Nester, MD, professor at the University of Iowa and lead principal investigator for the VALIANT study, discusses the clinical trial testing pegcetacoplan in patients with C3G and primary IC-MPGN. Complement 3 glomerulopathy (C3G) and immune-complex...
